Cargando…
Therapeutic Targeting of Exportin-1 in Childhood Cancer
SIMPLE SUMMARY: Exportin-1 is a nuclear transport protein that is overexpressed in cancer cells and associated with inferior outcomes across a range of malignancies. Selinexor is a novel FDA-approved inhibitor of Exportin-1 (XPO1). Although significant research has focused on integration of selinexo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699059/ https://www.ncbi.nlm.nih.gov/pubmed/34944778 http://dx.doi.org/10.3390/cancers13246161 |